zinc protoporphyrin ix has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kapoor, S | 1 |
Chen, C; Fang, Q; Li, Y; Ma, D; Wang, JS; Ynag, C; Yu, YY | 1 |
Gao, X; Lin, CH; Palma, JF; Solomon, WB; Wu, S | 1 |
3 other study(ies) available for zinc protoporphyrin ix and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Article | Year |
---|---|
The therapeutic benefits of heme oxygenase (HO-1) inhibition in the management of systemic malignancies besides hepatocellular carcinomas.
Topics: Antineoplastic Agents; Benzamides; Carcinoma, Hepatocellular; Enzyme Inhibitors; Heme Oxygenase-1; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Liver Neoplasms; Nasopharyngeal Neoplasms; Neoplasms; Piperazines; Protoporphyrins; Pyrimidines; Sarcoma, Kaposi | 2009 |
[CML cell apoptosis induced by AMN107 combined with heme oxygenase-1 inhibitor].
Topics: Apoptosis; Heme Oxygenase-1; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Protoporphyrins; Pyrimidines | 2012 |
Iron protoporphyrin IX (hemin) but not tin or zinc protoporphyrin IX can stimulate gene expression in K562 cells from enhancer elements containing binding sites for NF-E2.
Topics: Base Sequence; Binding Sites; Cell Line; Cell Nucleus; DNA-Binding Proteins; Enhancer Elements, Genetic; Erythroid-Specific DNA-Binding Factors; Gene Expression; Globins; Hemin; Humans; Kinetics; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Metalloporphyrins; Molecular Sequence Data; NF-E2 Transcription Factor; NF-E2 Transcription Factor, p45 Subunit; Protoporphyrins; RNA, Messenger; Transcription Factors; Tumor Cells, Cultured; Zinc Fingers | 1994 |